Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Biora Therapeutics Inc (BIOR)

Biora Therapeutics Inc (BIOR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Help
Go To:
Biora Therapeutics Successfully Completes Restructuring Process GlobeNewswire - Mon Mar 31, 2025

BIOR : 0.2200 (-50.01%)
Biora Therapeutics Undertakes Chapter 11 Sale Process to Position Business for Future Growth GlobeNewswire - Mon Dec 30, 2024

BIOR : 0.2200 (-50.01%)
Biora Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial Results GlobeNewswire - Thu Nov 14, 2024

BIOR : 0.2200 (-50.01%)
Biora Therapeutics to Report Third Quarter 2024 Financial Results and Provide Corporate Update GlobeNewswire - Thu Nov 7, 2024

BIOR : 0.2200 (-50.01%)
Biora Therapeutics Announces $3 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules GlobeNewswire - Tue Oct 29, 2024

BIOR : 0.2200 (-50.01%)
Biora Therapeutics Shares Progress on Smaller BioJet™ Clinical Device with Largest Payload of any Ingestible Injectable at the 14th Annual PODD Meeting GlobeNewswire - Mon Oct 28, 2024

BIOR : 0.2200 (-50.01%)
Biora Therapeutics to Reveal 00-Size BioJet™ Device at the 14th Annual Partnership Opportunities in Drug Delivery Meeting GlobeNewswire - Mon Oct 14, 2024

BIOR : 0.2200 (-50.01%)
Biora Therapeutics to Present at the 19th Annual Peptide Therapeutics Symposium GlobeNewswire - Mon Oct 7, 2024

BIOR : 0.2200 (-50.01%)
Biora Therapeutics Announces Successful Completion of Device Performance Study in Ulcerative Colitis Patients for its Targeted Therapeutics Platform Globe Newswire - Wed Aug 10, 2022

All Devices Successfully Detected Colon Entry in Patients with Active Ulcerative Colitis...

BIOR : 0.2200 (-50.01%)
Biora Therapeutics to Report Second Quarter 2022 Financial Results and Provide Corporate Update Globe Newswire - Mon Aug 8, 2022

SAN DIEGO, Aug. 08, 2022 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company that is reimagining therapeutics, today...

BIOR : 0.2200 (-50.01%)

Barchart Exclusives

Should You Buy Dividend-Paying Gold Stocks as Trump Makes Them ‘Great Again’? Barchart - Tue Jan 13, 6:30PM CST
Gold stocks have soared over the last year amid the rally in gold prices. Miners are paying handsome dividends as their cash flows have tracked gold prices higher. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot